Results 91 to 100 of about 10,641 (185)

Varenicline increases random flap survival in rats submitted to nicotine

, 2018
Smoking is a leading cause of flap failure. Varenicline-assisted smoking cessation has shown beneficial effects on vascular endothelial function. The aim of this study was to determine whether varenicline conveys beneficial effects for skin flap survival.
Bitik, Ozan, Ustun, Galip Gencay, ÇALIŞ, MERT, KÖSEMEHMETOĞLU, KEMAL, UZUN, HAKAN, AKSU, ALİ EMRE, Aksoyler, Dicle Yasar   +6 more
core   +1 more source

Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence

, 2016
Michael V Burke, J Taylor Hays, Jon O Ebbert Mayo Clinic, Rochester, MN, USA Abstract: Treating tobacco dependence is the most effective way to reduce tobacco-related death and disability.
Burke MV, Hays JT, Ebbert JO
core  

Effects of varenicline on lung tissue in the animal model

, 2020
WOS: 000530880900014PubMed ID: 32130342Objective: This study aimed to investigate acute and chronic effects of varenicline on lung tissue in an experimental study.
Gulbas, Gazi, Elbe, Hülya, Ermis, Hilal, Vardi, Nigar, Parlakpinar, Hakan, Polat, Alaaddin   +5 more
core   +1 more source

Clinical utility of varenicline for smokers with medical and psychiatric comorbidity

, 2009
Jon O Ebbert, Kirk D Wyatt, Ali Zirakzadeh, Michael V Burke, JT HaysMayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USAAbstract: Chronic obstructive pulmonary disease (COPD) is a costly and deadly disease afflicting an estimated 210
Kirk D Wyatt, et al, Ali Zirakzadeh, Jon O Ebbert   +3 more
core  

The effect of varenicline on the neural processing of fearful faces and the subjective effects of alcohol in heavy drinkers

, 2016
Background: Pharmacotherapies for alcohol use disorder have been shown to reduce hazardous drinking and improve overall health. The effect sizes for the effectiveness of these medications, however, are small, underscoring the need to expand the range of ...
Momenan, Reza, Heilig, Markus, Vatsalya, Vatsalya,, Ramchandani, Vijay A.,, Heilig, Markus,, Ramchandani, Vijay A., Schwandt, Melanie L.,, Westman, Jonathan G., Westman, Jonathan G.,, Bartlett, Selena,, Vatsalya, Vatsalya, Schwandt, Melanie L., Gowin, Joshua L., Gowin, Joshua L.,, Bartlett, Selena, Momenan, Reza,   +15 more
core   +1 more source

Haloperidol-induced parkinsonism is attenuated by varenicline in mice

, 2018
Background Parkinson’s disease (PD) is a neurodegenerative disorder of the central nervous system (CNS). However, there is no known drug to stop/slow down this neurodegeneration. Varenicline is an anti-smoking drug and has the potential
Ranjan K. Patel, Neeta Wardhan, Amit K. Sharma, Sparsh Gupta   +3 more
core   +1 more source

Cost-effectiveness of varenicline for smoking cessation

, 2009
Udgivelsesdato: JuneSmoking cessation therapies are among the most cost-effective preventive healthcare measures. Varenicline is a relatively new drug developed especially for this purpose, and it has been shown to achieve better quit rates than nicotine
Keiding, Hans
core   +1 more source

Varenicline may trigger severe hypoglycaemia in Type 1 diabetes

, 2008
Background Varenicline is a new drug indicated for smoking cessation. It has primarily been investigated in healthy adults. The commonest side-effects are nausea, headache, sleep disturbance, constipation, flatulence and vomiting.
Thorsteinsson, B., Pedersen-Bjergaard, U., Kristensen, P.L.   +2 more
core   +1 more source

Impact of preoperative varenicline on postoperative outcomes in cardiac surgery: comparison with nicotine replacement therapy and active smoking

The Cardiothoracic Surgeon
Background Nicotine dependence increases the risk of adverse outcomes after cardiac surgery, but there are no current established studies directly comparing different smoking cessation medications’ effect on postoperative outcomes.
Jason H. Yan, Vicky Shih, Nikhilesh Korgaonkar, Ebondo Mpinga, Quincy K. Tran, Rahul Kashyap   +5 more
doaj   +1 more source

Effect of varenicline on aspects of inhibitory control in smokers

, 2014
RATIONALE: Varenicline, a partial agonist at a4ß2 nicotinic receptors (nAChRs) aids smoking cessation by reducing craving. Successful quitting may be associated with greater inhibitory control but the effectiveness of varenicline in this regard is ...
A J Austin (16221413), A Jackson (9440984), Jennifer Rusted (4460485), Dora Duka (4460590)   +3 more
core